Atlas Trials

Ciprofloxacin Versus an Aminoglycoside Followed by Ciprofloxacin for Bubonic Plague

Clinical trial NCT04110340 · COMPLETED

Trial details

NCT number
NCT04110340
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Plague, BubonicPlague, Pneumonic
Start date
2020-02-15
Primary completion
2024-04-30
Enrollment
222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.